Intellia Therapeutics

8 followers

‌

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

201-500

Links

Org chart

John Leonard

President & CEO

John Leonard

Collapse

Eliana Clark

EVP, CTO

David Lebwohl

EVP, Chief Medical Officer

Derek Hicks

EVP, Chief Business Officer

Laura Sepp-Lorenzino

EVP, Chief Scientific Officer

Edward Dulac

EVP & CFO

Marika St. Amand

SVP, Chief Human Resources Officer

James Basta

EVP, General Counsel & Corporate Secretary

Aron Stein

SVP, Regulatory Affairs

Mary Ferguson

Senior Vice President, Head of Intellectual Property

Yuanxin Xu

SVP, Early Development & Transitional Medicine

Maria Natale

SVP, Commercial

Teams

+33

Research and Development

36 members

+31

Leadership Team

34 members

+19

Corporate Governance and Legal

22 members

Scientific and Technical Positions

11 members

Clinical Operations

11 members

Human Resources and Talent Management

6 members

Offices

Similar companies

Roivant Sciences

56 followers

Cytokinetics

12 followers

CRISPR Therapeutics

11 followers

Editas Medicine

5 followers

Denali Therapeutics

5 followers

Arrowhead Pharmaceuticals

4 followers

Arcus Biosciences

3 followers

Alector

3 followers

REGENXBIO

3 followers

Vir Biotechnology

3 followers

Arvinas

3 followers

Explore companies